Letter to the Editor
Anti C1q antibodies. A promising biomarker for cocaine-levamisole induced vasculitis
Anticuerpos anti C1q. Un biomarcador prometedor para la vasculitis inducida por cocaína-levamisol
José A. Gómez-Puertaa,b,
, Carlos H. Muñoza,c, Adriana L. Vanegas-Garcíaa,c, Tomás Urregod, Gloria Vásqueza,d, Luis A. Gonzáleza
Autor para correspondencia
jagomez@clinic.cat
Corresponding author at: Servicio de Reumatología, Hospital Clínic, Villarroel 170, Escala 11-2 Planta, 08036 Barcelona, Spain.
Corresponding author at: Servicio de Reumatología, Hospital Clínic, Villarroel 170, Escala 11-2 Planta, 08036 Barcelona, Spain.
Leído
5603
Vecesse ha leído el artículo
2166
Total PDF
3437
Total HTML
Compartir estadísticas
array:23 [ "pii" => "S1699258X17302760" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2017.11.002" "estado" => "S300" "fechaPublicacion" => "2019-09-01" "aid" => "1153" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "copyrightAnyo" => "2017" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2019;15:e66-e67" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 569 "formatos" => array:3 [ "EPUB" => 34 "HTML" => 189 "PDF" => 346 ] ] "itemSiguiente" => array:19 [ "pii" => "S1699258X17302735" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2017.10.014" "estado" => "S300" "fechaPublicacion" => "2019-09-01" "aid" => "1150" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2019;15:e68-e69" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 634 "formatos" => array:3 [ "EPUB" => 60 "HTML" => 219 "PDF" => 355 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>" "titulo" => "La aplicación de la calibración FRIDEX de la herramienta FRAX® para determinar el riesgo absoluto de fractura osteoporótica en mujeres españolas" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e68" "paginaFinal" => "e69" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "The application of the FRIDEX calibration of the FRAX tool to determine the absolute risk of osteoporotic fracture among Spanish women" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rafael Azagra, Paula Gabriel, Amada Aguyé, David Moriña" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Rafael" "apellidos" => "Azagra" ] 1 => array:2 [ "nombre" => "Paula" "apellidos" => "Gabriel" ] 2 => array:2 [ "nombre" => "Amada" "apellidos" => "Aguyé" ] 3 => array:2 [ "nombre" => "David" "apellidos" => "Moriña" ] 4 => array:1 [ "colaborador" => "en representación de GROIMAP" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173574318301758" "doi" => "10.1016/j.reumae.2017.10.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574318301758?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X17302735?idApp=UINPBA00004M" "url" => "/1699258X/0000001500000005/v1_201910230648/S1699258X17302735/v1_201910230648/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S1699258X17302449" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2017.09.006" "estado" => "S300" "fechaPublicacion" => "2019-09-01" "aid" => "1133" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2019;15:309-10" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 660 "formatos" => array:3 [ "EPUB" => 33 "HTML" => 306 "PDF" => 321 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Cat Scratch Disease During Adalimumab Therapy: A Case Report" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "309" "paginaFinal" => "310" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Enfermedad por arañazo de gato durante el tratamiento con adalimumab: a propósito de un caso" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1411 "Ancho" => 2500 "Tamanyo" => 291422 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A) Contrast-enhanced CT scan of the abdomen reveals a hypodense splenic nodule near the splenic hilum. (B) Abdominal ultrasound of the spleen depicts the same lesion as a hypoechoic nodule without posterior acoustic enhancement. (C) Cytology from lymphadenopathy's fine needle aspiration suggestive of granuloma inflammation.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Teresa Martins-Rocha, Cândida Abreu, Alexandra Bernardo, Miguel Bernardes, Joanne Lopes" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Teresa" "apellidos" => "Martins-Rocha" ] 1 => array:2 [ "nombre" => "Cândida" "apellidos" => "Abreu" ] 2 => array:2 [ "nombre" => "Alexandra" "apellidos" => "Bernardo" ] 3 => array:2 [ "nombre" => "Miguel" "apellidos" => "Bernardes" ] 4 => array:2 [ "nombre" => "Joanne" "apellidos" => "Lopes" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X17302449?idApp=UINPBA00004M" "url" => "/1699258X/0000001500000005/v1_201910230648/S1699258X17302449/v1_201910230648/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Anti C1q antibodies. A promising biomarker for cocaine-levamisole induced vasculitis" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e66" "paginaFinal" => "e67" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "José A. Gómez-Puerta, Carlos H. Muñoz, Adriana L. Vanegas-García, Tomás Urrego, Gloria Vásquez, Luis A. González" "autores" => array:6 [ 0 => array:4 [ "nombre" => "José A." "apellidos" => "Gómez-Puerta" "email" => array:1 [ 0 => "jagomez@clinic.cat" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Carlos H." "apellidos" => "Muñoz" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 2 => array:3 [ "nombre" => "Adriana L." "apellidos" => "Vanegas-García" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Tomás" "apellidos" => "Urrego" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "Gloria" "apellidos" => "Vásquez" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 5 => array:3 [ "nombre" => "Luis A." "apellidos" => "González" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Grupo de Reumatología, Universidad de Antioquia, Medellín, Colombia" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Reumatología, Hospital Clínic, Barcelona, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Hospital Universitario San Vicente Fundación, Medellín, Colombia" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Grupo de Inmunología Celular e Inmunogenética, GICIG, Universidad de Antioquia, Medellín, Colombia" "etiqueta" => "d" "identificador" => "aff0020" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author at: Servicio de Reumatología, Hospital Clínic, Villarroel 170, Escala 11-2 Planta, 08036 Barcelona, Spain." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Anticuerpos anti C1q. Un biomarcador prometedor para la vasculitis inducida por cocaína-levamisol" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">During the 1960s, Levamisole was used as an anthelmintic agent. It was subsequently found to have immunomodulatory effects and was used to treat several inflammatory disorders. During the last decade, attention has been focused on the use of levamisole as a cutting agent for cocaine and on several cases of severe agranulocytosis associated with cocaine use.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Cocaine/levamisole-induced vasculitis – LIVEN – is a heterogeneous vasculopathy characterized by skin necrosis concentrated in acral areas [ears, cheeks, genitals and digital necrosis], retiform purpura, general symptoms and cytopenias.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">2</span></a> Histopathological samples reveal pauci-inflammatory thrombotic diathesis accompanied with intravascular monocytes and evidence of complement activation.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">In 23 consecutive patients with systemic vasculitis from Hospital Universitario San Vicente Fundación, Medellín, Colombia, we analyzed the presence of Anti C1q antibodies, including antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, (<span class="elsevierStyleItalic">N</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>13), polyarteritis nodosa (<span class="elsevierStyleItalic">N</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>4), LIVEN (<span class="elsevierStyleItalic">N</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>4) and Takayasu arteritis (<span class="elsevierStyleItalic">N</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>2). Serum Anti-C1q were measured by ELISA techniques (QUANTA Lite, Inova, USA). This study was approved by the institutional review board at our institution.</p><p id="par0020" class="elsevierStylePara elsevierViewall">From this small pilot study, we found that anti C1q antibodies were more prevalent in LIVEN patients in comparison with other vasculitis (75% vs. 5.3%, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001). Mean anti C1q titers were significantly higher in patients with LIVEN than in other vasculitis (51.0<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>25.3 vs. 10.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>7.1<span class="elsevierStyleHsp" style=""></span>IU, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.04). Main clinical and serological characteristics including serum complement levels are summarized in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">It is well known that levamisole induces circulating autoantibodies. Patients commonly have high levels of perinuclear ANCA (p-ANCA) but not always against myeloperoxidase (MPO). p-ANCA titers are often directed against atypical p-ANCA-associated antigens within the neutrophil granules such as: human neutrophil elastase, lactoferrin, and cathepsin G.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">4</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">Recently, our group described a series of 11 patients with LIVEN.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">5</span></a> ANCA (91%), lupus anticoagulant (73%), ANAS (45%), anti dsDNA (29%), anti Ro (29%) were most common autoantibodies.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">5</span></a> Given the social difficulties for clinical follow-up in cocaine users, anti C1q antibodies are not measured yet in all patients with LIVEN attending our center.</p><p id="par0035" class="elsevierStylePara elsevierViewall">Anti C1q antibodies have been described in many conditions including hypocomplementic urticarial vasculitis, systemic lupus erythematosus and membranoproliferative glomerulonephritis, among others. To our knowledge, this study is the first on anti C1q antibodies in patients suffering LIVEN.</p><p id="par0040" class="elsevierStylePara elsevierViewall">C1q is a molecule important for the clearance of apoptotic cells. Apoptotic cells express autoantigens in their surface and may induce autoimmunity. Cocaine/levamisole generates repeated release of neutrophil antigens that might act as autoantigens and leads to decreasing tolerance. Neutrophils secrete complement proteins upon activation with PMA, fMLP and C5a. Neutrophil extracellular traps (NETs) have been implied as a potential source of autoantigens.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">6</span></a> Leffler et al.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">7</span></a> demonstrated that <span class="elsevierStyleItalic">in vitro</span> complement interaction with NETs and that C1q bound well and C3b deposited on NETs. The authors argue that decreased degradation of NETs led to deposition of complement and autoantibodies, recruitment of more complement, perpetuating the inflammatory cycle.</p><p id="par0045" class="elsevierStylePara elsevierViewall">Finally, metabolic products of cocaine promote complement synthesis and lead to the deposition of C5b-9. LIVEN is proposed as a membrane attack complex (C5b-9) disease with enhanced apoptosis and prominent vascular expression of ICAM-1.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">3</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">Increasing reports signal that LIVEN is a contemporary public health problem. Recent reports from different authorities in the U.S. and the U.K. suggest that cocaine samples are contaminated with levamisole in 50–80% of cases.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">8</span></a> According to local authorities in Colombia, levamisole contaminates 40% of the market.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">9</span></a> Indeed, preventing cocaine use is crucial for mitigating additional cases of LIVEN. Despite awareness of its toxicity by clinicians, identifying new biomarkers is necessary for practitioners that interface with these patients. Given our small sample size, further research is needed to confirm our findings that suggest anti C1q antibodies are useful markers in patients with LIVEN.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflict of interest</span><p id="par0055" class="elsevierStylePara elsevierViewall">The authors declare no conflict of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflict of interest" ] 1 => array:2 [ "identificador" => "xack430965" "titulo" => "Acknowledgments" ] 2 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Cyclo: cyclophosphamide, PDN: prednisolone, MPDN: methylprednisolone.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Case \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Age/gender \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Type of lesions \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Autoantibodies \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Serum complement<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Anti C1q antibodies \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Treatment \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">17/male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Ear necrosis, retiform purpura on legs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Anti MPO \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">C3: NormalC4: Normal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Positive (20.3<span class="elsevierStyleHsp" style=""></span>IU) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">PDN 30<span class="elsevierStyleHsp" style=""></span>mg/day \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">21/male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Rapidly progressive glomerulonephritis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Anti MPO, aCL IgG, aCL IgM, lupus anticoagulant \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">C3: LowC4: Low \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Positive (116.4<span class="elsevierStyleHsp" style=""></span>IU) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">PDN 60<span class="elsevierStyleHsp" style=""></span>mg/dayCyclo 1<span class="elsevierStyleHsp" style=""></span>g (pulses) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">25/female \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Ear necrosis, retiform purpura on legs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Anti MPO, aCL IgG \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">C3: NormalC4: Low \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Positive (64.4<span class="elsevierStyleHsp" style=""></span>IU) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">PDN 20<span class="elsevierStyleHsp" style=""></span>mg/day \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">36/male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Ear necrosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">ANAs, Anti dsDNAAnti MPO, Anti Ro \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">C3: NormalC4: Normal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Negative (3.1<span class="elsevierStyleHsp" style=""></span>IU) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">MPDN 500<span class="elsevierStyleHsp" style=""></span>mg pulses plus PDN 40<span class="elsevierStyleHsp" style=""></span>m/day \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2149838.png" ] ] ] "notaPie" => array:1 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Serum complement close to measurement of Anti-C1q antibodies.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Clinical and serological characteristics of LIVEN patients.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:9 [ 0 => array:3 [ "identificador" => "bib0050" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "K.C. Lee" 1 => "B. Ladizinski" 2 => "D.G. Federman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.mayocp.2012.03.010" "Revista" => array:6 [ "tituloSerie" => "Mayo Clin Proc" "fecha" => "2012" "volumen" => "87" "paginaInicial" => "581" "paginaFinal" => "586" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22677078" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0055" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pauci-immune glomerulonephritis in individuals with disease associated with levamisole-adulterated cocaine: a series of 4 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.Q. Carlson" 1 => "D.S. Tuot" 2 => "K.Y. Jen" 3 => "B. Butcher" 4 => "J. Graf" 5 => "R. Sam" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Medicine (Baltimore)" "fecha" => "2014" "volumen" => "93" "paginaInicial" => "290" "paginaFinal" => "297" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0060" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cocaine-associated retiform purpura: a C5b-9-mediated microangiopathy syndrome associated with enhanced apoptosis and high levels of intercellular adhesion molecule-1 expression" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C.M. Magro" 1 => "X. Wang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/DAD.0b013e31827eaf0b" "Revista" => array:6 [ "tituloSerie" => "Am J Dermatopathol" "fecha" => "2013" "volumen" => "35" "paginaInicial" => "722" "paginaFinal" => "730" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23392134" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0065" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vasculitis associated with levamisole and circulating autoantibodies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R. Laux-End" 1 => "D. Inaebnit" 2 => "H.A. Gerber" 3 => "M.G. Bianchetti" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/adc.75.4.355-b" "Revista" => array:6 [ "tituloSerie" => "Arch Dis Child" "fecha" => "1996" "volumen" => "75" "paginaInicial" => "355" "paginaFinal" => "356" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8984931" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0070" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cocaine-levamisole induced vasculitis: a series of 11 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.H. Muñoz" 1 => "A.L. Vanegas" 2 => "A. Arbelaez" 3 => "M. Restrepo" 4 => "G. Vásquez" 5 => "L.A. Correa" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2016" "volumen" => "75" "numero" => "Suppl. 2" "paginaInicial" => "567" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0075" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C. Lood" 1 => "G.C. Hughes" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Rheumatology (Oxford)" "fecha" => "2016" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0080" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Leffler" 1 => "M. Martin" 2 => "B. Gullstrand" 3 => "H. Tydén" 4 => "C. Lood" 5 => "L. Truedsson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4049/jimmunol.1102404" "Revista" => array:6 [ "tituloSerie" => "J Immunol" "fecha" => "2012" "volumen" => "188" "paginaInicial" => "3522" "paginaFinal" => "3531" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22345666" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0085" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Identification of levamisole impurities found in illicit cocaine exhibits" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.F. Casale" 1 => "E.M. Corbeil" 2 => "A.H. Patrick" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Microgram J" "fecha" => "2008" "volumen" => "6" "paginaInicial" => "82" "paginaFinal" => "89" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0090" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "<a target="_blank" href="https://www.unodc.org/documents/colombia/2014/Julio/Estudio_de_Consumo_UNOD.C.pdf">https://www.unodc.org/documents/colombia/2014/Julio/Estudio_de_Consumo_UNOD.C.pdf</a> [accessed 24.07.16]." ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack430965" "titulo" => "Acknowledgments" "texto" => "<p id="par0060" class="elsevierStylePara elsevierViewall">J.A. Gómez-Puerta was supported by <span class="elsevierStyleGrantSponsor" id="gs1">Colciencias</span> (convocatoria 656 de 2014). We would like to thank Catalina Perez Koller and Liliana Marcela Peñaranda (Inova/Wefen) for assisting with sample management and analysis of antibodies.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/1699258X/0000001500000005/v1_201910230648/S1699258X17302760/v1_201910230648/en/main.assets" "Apartado" => array:4 [ "identificador" => "17506" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Cartas al editor" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/1699258X/0000001500000005/v1_201910230648/S1699258X17302760/v1_201910230648/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X17302760?idApp=UINPBA00004M" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 2 | 6 | 8 |
| 2024 Octubre | 48 | 23 | 71 |
| 2024 Septiembre | 43 | 24 | 67 |
| 2024 Agosto | 54 | 27 | 81 |
| 2024 Julio | 55 | 27 | 82 |
| 2024 Junio | 54 | 33 | 87 |
| 2024 Mayo | 47 | 22 | 69 |
| 2024 Abril | 73 | 37 | 110 |
| 2024 Marzo | 68 | 32 | 100 |
| 2024 Febrero | 104 | 28 | 132 |
| 2024 Enero | 45 | 22 | 67 |
| 2023 Diciembre | 124 | 25 | 149 |
| 2023 Noviembre | 56 | 25 | 81 |
| 2023 Octubre | 63 | 35 | 98 |
| 2023 Septiembre | 64 | 38 | 102 |
| 2023 Agosto | 30 | 12 | 42 |
| 2023 Julio | 54 | 34 | 88 |
| 2023 Junio | 56 | 21 | 77 |
| 2023 Mayo | 36 | 19 | 55 |
| 2023 Abril | 48 | 9 | 57 |
| 2023 Marzo | 72 | 23 | 95 |
| 2023 Febrero | 61 | 24 | 85 |
| 2023 Enero | 49 | 12 | 61 |
| 2022 Diciembre | 75 | 40 | 115 |
| 2022 Noviembre | 77 | 31 | 108 |
| 2022 Octubre | 76 | 43 | 119 |
| 2022 Septiembre | 84 | 23 | 107 |
| 2022 Agosto | 65 | 49 | 114 |
| 2022 Julio | 51 | 36 | 87 |
| 2022 Junio | 47 | 32 | 79 |
| 2022 Mayo | 49 | 47 | 96 |
| 2022 Abril | 106 | 47 | 153 |
| 2022 Marzo | 69 | 39 | 108 |
| 2022 Febrero | 56 | 38 | 94 |
| 2022 Enero | 40 | 45 | 85 |
| 2021 Diciembre | 52 | 41 | 93 |
| 2021 Noviembre | 66 | 42 | 108 |
| 2021 Octubre | 35 | 42 | 77 |
| 2021 Septiembre | 34 | 46 | 80 |
| 2021 Agosto | 29 | 34 | 63 |
| 2021 Julio | 27 | 36 | 63 |
| 2021 Junio | 27 | 43 | 70 |
| 2021 Mayo | 45 | 45 | 90 |
| 2021 Abril | 137 | 120 | 257 |
| 2021 Marzo | 72 | 31 | 103 |
| 2021 Febrero | 47 | 25 | 72 |
| 2021 Enero | 56 | 34 | 90 |
| 2020 Diciembre | 45 | 24 | 69 |
| 2020 Noviembre | 49 | 27 | 76 |
| 2020 Octubre | 32 | 24 | 56 |
| 2020 Septiembre | 78 | 41 | 119 |
| 2020 Agosto | 75 | 24 | 99 |
| 2020 Julio | 42 | 19 | 61 |
| 2020 Junio | 38 | 18 | 56 |
| 2020 Mayo | 50 | 30 | 80 |
| 2020 Abril | 45 | 20 | 65 |
| 2020 Marzo | 65 | 26 | 91 |
| 2020 Febrero | 1 | 0 | 1 |
| 2019 Diciembre | 4 | 4 | 8 |
| 2019 Noviembre | 3 | 4 | 7 |
| 2019 Octubre | 2 | 0 | 2 |
| 2019 Septiembre | 3 | 2 | 5 |
| 2019 Mayo | 43 | 24 | 67 |
| 2019 Abril | 30 | 74 | 104 |
| 2019 Marzo | 30 | 24 | 54 |
| 2019 Febrero | 18 | 11 | 29 |
| 2019 Enero | 15 | 18 | 33 |
| 2018 Diciembre | 41 | 33 | 74 |
| 2018 Noviembre | 0 | 19 | 19 |
| 2018 Octubre | 0 | 10 | 10 |
| 2018 Septiembre | 0 | 12 | 12 |
| 2018 Agosto | 0 | 11 | 11 |
| 2018 Julio | 0 | 6 | 6 |
| 2018 Mayo | 0 | 2 | 2 |
| 2018 Abril | 0 | 1 | 1 |
| 2018 Marzo | 0 | 15 | 15 |
| 2018 Febrero | 0 | 32 | 32 |
| 2018 Enero | 0 | 22 | 22 |
| 2017 Diciembre | 0 | 22 | 22 |
Mostrar todo
